Search

everythinglearnresearchcommunity

for

Search:↓

Cicatricial alopecia may be caused by immune attacks on hair follicles, gland issues, or stem cell damage.

People with non-scarring hair loss have higher levels of DKK-1, a protein linked to hair growth, than those with scarring hair loss or no hair loss.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

Middle-aged women in Iran are most affected by primary cicatricial alopecia, especially discoid lupus erythematous.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

Damage to hair follicle stem cells causes permanent hair loss and scarring in cutaneous lupus erythematosus.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Deleting the Far2 gene in mice causes sebaceous gland issues and patchy hair loss.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

Vitamin A may influence hair loss conditions like alopecia, but more research is needed to understand how.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Primary idiopathic pseudopelade of Brocq causes gradual, scarring hair loss with no effective treatment.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The Hair India 2010 conference introduced a new hair loss classification and highlighted advanced diagnostic techniques in trichology.

A woman has a permanent hair loss condition treated with steroids and new medicines, but hair might not regrow.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Blocking cholesterol production may help control hair loss in Primary Cicatricial Alopecia by affecting key regulators.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.